122 related articles for article (PubMed ID: 27751997)
1.
Osman NA; El-Abd N; Nasrallah M
Saudi J Kidney Dis Transpl; 2016; 27(5):908-915. PubMed ID: 27751997
[TBL] [Abstract][Full Text] [Related]
2. G-1639A but Not C1173T
Dubovyk YI; Harbuzova VY; Ataman AV
Biomed Res Int; 2016; 2016():1298198. PubMed ID: 27703968
[TBL] [Abstract][Full Text] [Related]
3. VKORC1 C1173T and VKORC1 G-1639A gene polymorphisms in Turkish Behçet's patients with ocular and non-ocular involvement.
Demir HD; Ortak H; Şahin Ş; Ateş Ö; Benli I; İnanır A
Ophthalmic Genet; 2014 Mar; 35(1):7-11. PubMed ID: 23362849
[TBL] [Abstract][Full Text] [Related]
4. Sequence variation in vitamin K epoxide reductase gene is associated with survival and progressive coronary calcification in chronic kidney disease.
Holden RM; Booth SL; Tuttle A; James PD; Morton AR; Hopman WM; Nolan RL; Garland JS
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1591-6. PubMed ID: 24855061
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of the vitamin K epoxide reductase complex subunit 1 G-1639A and C1173T single nucleotide polymorphisms in retinal vein occlusion.
Ortak H; Söğüt E; Demir H; Ardagil A; Benli I; Sahin S
Clin Exp Ophthalmol; 2012; 40(7):743-8. PubMed ID: 22394334
[TBL] [Abstract][Full Text] [Related]
6. Susceptiveness of Vitamin K epOxide Reductase Complex Subunit 1 Gene Polymorphism in Essential Hypertension.
Turgut Cosan D; Yazıcı HU; Colak E; Soyocak A; Degirmenci I; Kurt H; Birdane A; Colak E; Gunes HV
Genet Test Mol Biomarkers; 2017 May; 21(5):292-297. PubMed ID: 28281786
[TBL] [Abstract][Full Text] [Related]
7. Missense mutation of VKORC1 leads to medial arterial calcification in rats.
Michaux A; Matagrin B; Debaux JV; Schurgers LJ; Benoit E; Lattard V
Sci Rep; 2018 Sep; 8(1):13733. PubMed ID: 30214074
[TBL] [Abstract][Full Text] [Related]
8. Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients.
Brancaccio D; Biondi ML; Gallieni M; Turri O; Galassi A; Cecchini F; Russo D; Andreucci V; Cozzolino M
Am J Nephrol; 2005; 25(6):548-52. PubMed ID: 16210837
[TBL] [Abstract][Full Text] [Related]
9. Is a Vitamin K Epoxide Reductase Complex Subunit 1 (
Drent M; Wijnen P; Bekers O; Bast A
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674033
[TBL] [Abstract][Full Text] [Related]
10. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection).
Wang Y; Zhang W; Zhang Y; Yang Y; Sun L; Hu S; Chen J; Zhang C; Zheng Y; Zhen Y; Sun K; Fu C; Yang T; Wang J; Sun J; Wu H; Glasgow WC; Hui R
Circulation; 2006 Mar; 113(12):1615-21. PubMed ID: 16549638
[TBL] [Abstract][Full Text] [Related]
11. Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study.
Holzer G; Grasse AV; Zehetmayer S; Bencur P; Bieglmayer C; Mannhalter C
Transl Res; 2010 Jul; 156(1):37-44. PubMed ID: 20621035
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin.
Teh LK; Langmia IM; Fazleen Haslinda MH; Ngow HA; Roziah MJ; Harun R; Zakaria ZA; Salleh MZ
J Clin Pharm Ther; 2012 Apr; 37(2):232-6. PubMed ID: 21507031
[TBL] [Abstract][Full Text] [Related]
13. VKORC1 and the vitamin K cycle.
Garcia AA; Reitsma PH
Vitam Horm; 2008; 78():23-33. PubMed ID: 18374188
[TBL] [Abstract][Full Text] [Related]
14. [The matrix-gla protein awakening may lead to the demise of vascular calcification].
Delanaye P; Liabeuf S; Bouquegneau A; Cavalier É; Massy ZA
Nephrol Ther; 2015 Jul; 11(4):191-200. PubMed ID: 25794931
[TBL] [Abstract][Full Text] [Related]
15. Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study.
Teichert M; Visser LE; van Schaik RH; Hofman A; Uitterlinden AG; De Smet PA; Witteman JC; Stricker BH
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):771-6. PubMed ID: 18218987
[TBL] [Abstract][Full Text] [Related]
16. Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A gene polymorphism in patients with retinal vein occlusion.
Weger M; Steinbrugger I; Renner W; Pöschl EM; Brockmann T; Rabensteiner DF; El-Shabrawi Y; Haas A
Curr Eye Res; 2013 Dec; 38(12):1278-82. PubMed ID: 23972066
[TBL] [Abstract][Full Text] [Related]
17. Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease.
Karsli Ceppioğlu S; Yurdun T; Canbakan M
Ren Fail; 2011; 33(9):866-74. PubMed ID: 21859400
[TBL] [Abstract][Full Text] [Related]
18. Association of VKORC1 -1639 G>A polymorphism with carotid intima-media thickness in type 2 diabetes mellitus.
Tavridou A; Petridis I; Vasileiadis M; Ragia G; Heliopoulos I; Vargemezis V; Manolopoulos VG
Diabetes Res Clin Pract; 2011 Nov; 94(2):236-41. PubMed ID: 21767890
[TBL] [Abstract][Full Text] [Related]
19. Vitamin K epoxide reductase complex 1 (VKORC1) gene polymorphisms in population of Eastern Croatia.
Mandić D; Mandić S; Horvat V; Samardzija M; Samardzija M
Coll Antropol; 2013 Dec; 37(4):1321-6. PubMed ID: 24611351
[TBL] [Abstract][Full Text] [Related]
20. Association between VKORC1 gene polymorphisms and ischemic cerebrovascular disease in Chinese Han population.
Zhang H; Yang L; Feng Q; Fan Y; Zheng H; He Y
J Mol Neurosci; 2014 Jun; 53(2):166-70. PubMed ID: 24535562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
